Miren Taberna (Spain)
Institut català d'Oncologia Medical Oncology Department
Presenter of 2 Presentations
Diagnosing and management of HPV-associated oropharyngeal cancer (ID 32)
Session Time
11:00 - 12:25
Session Type
Clinical Science
Lecture Time
11:43 - 12:03
ETIOLOGICAL FACTORS IN OROPHARYNX AND ORAL CAVITY SQUAMOUS CELL CARCINOMA DIAGNOSED AT YOUNG AGE: A SPANISH COHORT AND AN USA CASE-CONTROL STUDY. (ID 1271)
Session Time
10:00 - 17:00
Session Type
Poster Viewing - 20-24 July
Session Name
Clinical Research / Diagnosis and Management of Oropharyngeal, Head and Neck Cancer
Lecture Time
10:03 - 10:04
Introduction
There is a gap in knowledge in the etiological factors in head and neck cancers diagnosed at young age. The aim of this study is to compare the demographic, toxic habits and HPV status between a Spanish retrospective cohort of oropharyngeal cancer (OPC) patients (≤45 years old vs >45 years). Furthermore, we have analyzed the toxic habits status between young cases and controls from an USA case-control study (including OPC and oral cavity cancers-OC).
Methods
We have reanalyzed data from a retrospective cohort of patients diagnosed with OPC in four Catalonian hospitals from 1990 to 2017 and a case-control study in USA from 2011 to 2014 at The Ohio State University Medical Center. In the OPC cohort unconditional logistic regression was used to compare age groups. Differences in characteristics between cases and controls were compared using the Pearson’s Chi2 test.
Results
49 young and 816 old OPC patients were included from the Spanish cohort and 23 young cases and 46 controls from the USA study. Spanish cohort characteristics comparing young and old OPC patients are described in Table 1. No significant differences were reported in gender, toxic habits or HPV status (positivity: 12.2% vs 7.5% in young and old OPC patients, respectively). There were more non-smokers HPV-related OPC patients than HPV-negative ones (p-value<0.001) in both age groups. A descriptive of the toxic habits of the patients with OC stratified by case or control in the USA study is describe in table 2. There were no statistically significant differences between cases and controls for all toxic habits evaluated; 57.8% of cases (24) were HPV-positive.
Conclusions
No significant differences were reported in gender, toxic habits or HPV status between young and old OPC patients; neither between young cases and controls regarding tobacco, alcohol or marijuana use.
Hide
Moderator of 1 Session
Session Type
Clinical Science Oral Session
Session Time
07:30 - 08:10
[{"name":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA \u003Csmall\u003E(ID 314)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":314,"presentation":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA \u003Csmall\u003E(ID 314)\u003C\/small\u003E","session":"Oral Session 7: Oropharyngeal Cancer - Biomarkers for Diagnosis and Prognosis","presenter":"Peter L. Stern (United Kingdom)","photo":""},"playlist":[{"name":"SPATIAL PROXIMITY BETWEEN T AND PD-L1 EXPRESSING CELLS AS A PROGNOSTIC BIOMARKER FOR OROPHARYNGEAL S","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/BF99522.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/P314_S_960_Updated.vtt"}]},{"name":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE: AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH \u003Csmall\u003E(ID 814)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":814,"presentation":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE: AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH \u003Csmall\u003E(ID 814)\u003C\/small\u003E","session":"Oral Session 7: Oropharyngeal Cancer - Biomarkers for Diagnosis and Prognosis","presenter":"Ligia A. Pinto (United States of America)","photo":""},"playlist":[{"name":"THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/19360B26.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/78\/Ligia Pinto IPVC20 814 THE HPV SEROLOGY STANDARDIZATION INITIATIVE AIMS AND PROGRESS TO DATE AT THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH.vtt"}]}]
{"type":2,"code":"6E32UU02m"}
[session]
[presentation]
[presenter]